-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on QuidelOrtho, Raises Price Target to $45

Benzinga·02/13/2025 14:39:15
Listen to the news
UBS analyst John Sourbeer maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and raises the price target from $43 to $45.